Direkt zum Inhalt
Fachrepositorium Lebenswissenschaften
Freier Zugang zu Wissensressourcen aus den Lebenswissenschaften
Suche
Publisso-Menue
Publizieren
PUBLISSO-System
Bücher
Policy Bücher
Bücher Übersicht
Zeitschriften / Artikel
Journals Übersicht
Serien
Policy Serien
MAK Collection
Kongresse
Forschungsdaten
Repositorien
Fachrepositorium Lebenswissenschaften
Publizieren im Fachrepositorium
LeibnizOpen
Beraten
Forschungsdatenmanagement
Digitale Langzeitarchivierung
Wir für Sie
Volltexte
Filter (Auswahl)
Lung Neoplasms/pathology [MeSH]
[x]
Sacherschließung
Lung Neoplasms/therapy [MeSH]
(10)
Humans [MeSH]
(9)
Middle Aged [MeSH]
(7)
Female [MeSH]
(7)
Adult [MeSH]
(7)
Neoplasm Staging [MeSH]
(5)
Male [MeSH]
(4)
Lung Neoplasms/mortality [MeSH]
(4)
Aged [MeSH]
(4)
Publikationstyp
Artikel
(10)
Medium
Erscheinungsjahr
2024
(5)
2023
(1)
2021
(2)
2020
(2)
Institution
10 Treffer
Kurzansicht
E-Jahr
Zugriff
Typ
Operations
Effect of TTF-1 expression on progression free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer
2024 .
Uhlenbruch, Mark
|
Krüger, Stefan
2024
http://purl.org/ontology/bibo/Article
Prognostic value of metabolic tumor volume on [18F]FDG PET/CT in addition to the TNM classification system of locally advanced non-small cell lung cancer
2024 .
Brose, Alexander
|
Miederer, Isabelle
|
König, Jochem
|
Gkika, Eleni
|
Sahlmann, Jörg
|
Schimek-Jasch, Tanja
|
Schreckenberger, Mathias
|
Nestle, Ursula
|
Kappes, Jutta
|
Miederer, Matthias
2024
http://purl.org/ontology/bibo/Article
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
2024 .
Xie, Mingchao
|
Vuko, Miljenka
|
Rodriguez-Canales, Jaime
|
Zimmermann, Johannes
|
Schick, Markus
|
O’Brien, Cathy
|
Paz-Ares, Luis
|
Goldman, Jonathan W.
|
Garassino, Marina Chiara
|
Gay, Carl M.
|
Heymach, John V.
|
Jiang, Haiyi
|
Barrett, J. Carl
|
Stewart, Ross A.
|
Lai, Zhongwu
|
Byers, Lauren A.
|
Rudin, Charles M.
|
Shrestha, Yashaswi
2024
http://purl.org/ontology/bibo/Article
Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer
2024 .
Li, Yutao
|
Sharma, Amit
|
Schmidt-Wolf, Ingo G.H.
2024
http://purl.org/ontology/bibo/Article
Age differences in the treatment of lung cancer–a cohort study among 42,000 patients from Germany
2024 .
Rischke, Nikolaj
|
Kanbach, Josephine
|
Haug, Ulrike
2024
http://purl.org/ontology/bibo/Article
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis
2023 .
Hofstetter, Kerstin
|
Taugner, Julian
|
Käsmann, Lukas
|
Mansoorian, Sina
|
Flörsch, Benedikt
|
Eze, Chukwuka
|
Tufman, Amanda
|
Reinmuth, Niels
|
Duell, Thomas
|
Belka, Claus
|
Manapov, Farkhad
2023
http://purl.org/ontology/bibo/Article
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
2021 .
Taugner, Julian
|
Käsmann, Lukas
|
Karin, Monika
|
Eze, Chukwuka
|
Flörsch, Benedikt
|
Guggenberger, Julian
|
Li, Minglun
|
Tufman, Amanda
|
Reinmuth, Niels
|
Duell, Thomas
|
Belka, Claus
|
Manapov, Farkhad
2021
http://purl.org/ontology/bibo/Article
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
2021 .
Taugner, Julian
|
Käsmann, Lukas
|
Eze, Chukwuka
|
Rühle, Alexander
|
Tufman, Amanda
|
Reinmuth, Niels
|
Duell, Thomas
|
Belka, Claus
|
Manapov, Farkhad
2021
http://purl.org/ontology/bibo/Article
Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma
2020 .
,
|
Shi, Run
|
Zhao, Tianyu
|
Wang, Yanfang
2020
http://purl.org/ontology/bibo/Article
Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
2020 .
Bozorgmehr, Farastuk
|
Chung, Inn
|
Christopoulos, Petros
|
Krisam, Johannes
|
Schneider, Marc A.
|
Brückner, Lena
|
Mueller, Daniel Wilhelm
|
Thomas, Michael
|
Rieken, Stefan
2020
http://purl.org/ontology/bibo/Article